Sales of Moderna’s COVID-19 shot exceeded expectations, but the company’s launch of its new RSV vaccine has started slowly.
While Moderna’s Spikevax beat Wall Street estimates in the third quarter, William Blair analyst Myles Minter in a Thursday ...
Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...
He’s taking over a commercial assignment that was held by Stephane Bancel, who will remain chief executive officer. The ...
Moderna reported better third-quarter results than expected Thursday morning, as the vaccine maker reported a surprise profit ...
Moderna Inc.’s stock jumped 5% early Thursday, after the company’s third-quarter earnings showed an unexpected profit and ...
Moderna said its newest Covid vaccine saw benefits after winning approval in the U.S. three weeks earlier than the last ...
Welcome to the Moderna third quarter 2024 conference call. [Operator instructions] Please be advised today's conference is ...
“I am pleased with the cost efficiency we achieved in the quarter, tracking ahead of where we planned to be at this time,” ...